Overview

Full Product Details

Author:   Haruo Shintaku ,  Akira Oka ,  Makoto Nabetani
Publisher:   Springer Verlag, Singapore
Imprint:   Springer Verlag, Singapore
Edition:   1st ed. 2018
Weight:   3.724kg
ISBN:  

9789811014116

ISBN 10:   9811014116
Pages:   150
Publication Date:   15 March 2018
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1. Clinical trial of autologous cord blood cell therapy for neonatal hypoxic‐ischemic encephalopathy (HIE).- 2. New strategy of clinical studies for premature babies with ischemic brain damage .- 3. Pathophysiology and pathology of neonatal hypoxic-ischemic encephalopathy.- 4. Neural stem/progenitor cells for perinatal brain injury.- 5. Hematopoietic stem cells for perinatal brain injury.- 6. Umbilical cord-derived mesenchymal stromal cells for perinatal brain injury.- 7. Other tissues-derived mesenchymal stem cells for perinatal brain injury.- 8. CD34+ cell in cord blood and neonates.- 9. The History of Hypothermia therapy for perinatal ischemic brain injury.- 10. Clinical Procedure of Cell Therapy (Cord blood collection).- 11. Clinical Procedure of Cell Therapy (Separation and infusion).- 12. Cell therapy for adult infarction.- 13. Clinical trials on cell therapy for perinatal brain injury: Challenges and opportunities.- 14. A new prospective cell therapy for neonatal brain injury.

Reviews

This book reviews advances the evolving cell therapy for various neonatal ischemic diseases. It has 14 chapters, with tables, illustrations and many references. For pediatric neonatologists, hematologists and researchers in biology. (Pediatric Endocrinology Reviews (PER), Vol. 16 (1), September, 2018) The book is aimed mostly at researchers, especially those involved in stem cell therapy. However, neonatologists and pediatric neurologists will find the concepts intriguing and sometimes exciting. The authors seem to be well regarded in this field. ... This is a provocative monograph that certainly could inform discussions on this cutting-edge therapy. ... For those curious about this novel therapy, this is an interesting read. (Jay P. Goldsmith, Doody's Book Reviews, May, 2018)

The book is aimed mostly at researchers, especially those involved in stem cell therapy. However, neonatologists and pediatric neurologists will find the concepts intriguing and sometimes exciting. The authors seem to be well regarded in this field. ... This is a provocative monograph that certainly could inform discussions on this cutting-edge therapy. ... For those curious about this novel therapy, this is an interesting read. (Jay P. Goldsmith, Doody's Book Reviews, May, 2018)

“This book reviews advances the evolving cell therapy for various neonatal ischemic diseases. It has 14 chapters, with tables, illustrations and many references. For pediatric neonatologists, hematologists and researchers in biology.” (Pediatric Endocrinology Reviews (PER), Vol. 16 (1), September, 2018) “The book is aimed mostly at researchers, especially those involved in stem cell therapy. However, neonatologists and pediatric neurologists will find the concepts intriguing and sometimes exciting. The authors seem to be well regarded in this field. … This is a provocative monograph that certainly could inform discussions on this cutting-edge therapy. … For those curious about this novel therapy, this is an interesting read.” (Jay P. Goldsmith, Doody's Book Reviews, May, 2018)

Author Information

Haruo ShintakuDepartment of Pediatrics,Osaka City University Graduate School of Medicine,OsakaJapan Akira OkaDepartment of Pediatrics,University of Tokyo, TokyoJapan Makoto Nabetani, Department of Pediatrics,Yodogawa Christian Hospital, Osaka,Japan

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions